S'abonner

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China - 20/03/20

Doi : 10.1016/j.jinf.2020.02.016 
Wenjie Yang a, 1, Qiqi Cao a, 1, Le Qin a, 1, Xiaoyang Wang b, 1, Zenghui Cheng a, Ashan Pan c, Jianyi Dai d, Qingfeng Sun e, Fengquan Zhao d, Jieming Qu f, , Fuhua Yan a,
a Department of Radiology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, No.197 Ruijin Er Road, Shanghai 200025, China 
b Department of Radiology, Ruian People's Hospital, Ruian 325200, Zhejiang province, China 
c Department of Radiology, Yueqing People's Hospital, Yueqing 325600, Zhejiang province, China 
d Department of Infectious Diseases, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang province, China 
e Department of Infectious Diseases, Ruian People's Hospital, Ruian 325200, Zhejiang province, China 
f Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, No.197 Ruijin Er Road, Shanghai 200025, China 

Corresponding authors.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China.

Methods

In this retrospective cohort study, 149 RT-PCR confirmed positive patients were consecutively enrolled from January 17th to February 10th, 2020 in three tertiary hospitals of Wenzhou. Outcomes were followed up until Feb 15th, 2020.

Findings

A total of 85 patients had Hubei travel/residence history, while another 49 had contact with people from Hubei and 15 had no traceable exposure history to Hubei. Fever, cough and expectoration were the most common symptoms, 14 patients had decreased oxygen saturation, 33 had leukopenia, 53 had lymphopenia, and 82 had elevated C-reactive protein. On chest computed tomography (CT), lung segments 6 and 10 were mostly involved. A total of 287 segments presented ground glass opacity, 637 presented mixed opacity and 170 presented consolidation. Lesions were more localized in the peripheral lung with a patchy form. No significant difference was found between patients with or without Hubei exposure history. Seventeen patients had normal CT on admission of these, 12 had negative findings even10 days later.

Interpretation

Most patients presented with a mild infection in our study. The imaging pattern of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset. Nevetheless, some patients can present with a normal chest finding despite testing positive for COVID-19. Funding: We did not receive any fundings.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Infection, Outside Hubei, CT, Lung


Plan


© 2020  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 4

P. 388-393 - avril 2020 Retour au numéro
Article précédent Article précédent
  • Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients
  • Cecilie B. Hansen, Rafael Bayarri-Olmos, Markus K. Kristensen, Katrine Pilely, Dorthe Hellemann, Peter Garred
| Article suivant Article suivant
  • Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2
  • Yu-Huan Xu, Jing-Hui Dong, Wei-Min An, Xiao-Yan Lv, Xiao-Ping Yin, Jian-Zeng Zhang, Li Dong, Xi Ma, Hong-Jie Zhang, Bu-Lang Gao

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.